Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection
H. Sakugawa et al., Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection, J MED VIROL, 65(3), 2001, pp. 478-484
To clarify the correlation between hepatitis B virus (HBV) DNA levels and s
erum alanine aminotransferase (ALT) levels in patients with established chr
onic hepatitis delta virus (HDV) infection, sensitive HBV quantitative assa
ys were used! for the study. Thirty-four consecutive patients with chronic
liver disease who were positive for both hepatitis B surface antigen (HBsAg
) and antibody to HDV (anti-HDV), including 19 patients with chronic hepati
tis, 8 patients with liver cirrhosis and 7 patients with hepatocellular car
cinoma. All were negative for hepatitis Be antigen (HBeAg) and positive for
antibody to HBeAg. HBV DNA was detected in 25 (73.5%) of the 34 patients u
sing real-time detection PCR, and the HBV DNA levels of these patients were
significantly lower compared with kBeAg status and ALT level-matched patie
nts with chronic liver disease positive for HBsAg but negative for anti-HDV
. There was no correlation between serum HBV DNA and ALT levels among the 3
4 patients with chronic liver disease positive for anti-HDV. Whereas serum
ALT levels in anti-HDV-positive HBsAg carriers with HDV RNA were significan
tly higher than those without HDV RNA. Liver damage in, patients with estab
lished chronic HDV infection may be caused mainly by ongoing HDV infection
not by HBV replication. (C) 2001 Wiley-Liss, Inc.